Severe Aplastic Anaemia Working Party (SAAWP)
Type of Stem Cell Treatment:
RACE-2: long-term follow-up
To evaluate the long-term outcome and survival of patients who have received standard IST with or without Eltrombopag within the RACE trial.
Key inclusion criteria:
Subject participated in the RACE trial (EudraCT number: 2014-000363-40) during which patient received ATGAM, Cyclosporine A with or without Eltrombopag.
Régis Peffault de Latour, Antonio M. Risitano
EBMT Study coordinator:
Study coordinator email: